Dr Andrew Chancellor, an Englishman by birth, is a graduate of Auckland Medical School, with neurology training in The Department of Neurology, Auckland Hospital. Thereafter, he spent five years in the UK, both as a research fellow and senior registrar, mostly in The Department of Clinical Neurosciences, Edinburgh.
Andrew returned to Edinburgh, an area of high multiple sclerosis prevalence, in 2003-04, as a locum consultant. In 1994 he was awarded an MD (Auckland University) based on research in motor neuron disease.
Eclectic interests are reflected in more than 2 dozen papers published in peer reviewed journals, including a prevalence study of MS in the Bay of Plenty (BOP).
Andrew has worked in the BOP since 1994, consulting for in-patient care but with a predominately out-patient based practice. He continues his interest in MND, supporting the MNDA of NZ; runs a comprehensive regional multiple sclerosis clinic and helps with the work of The National CJD Surveillance Registry. He is a senior examiner for the College of Physicians; an ex-president of the Neurological Association of NZ and serves on the editorial board of the journal ‘Practical Neurology’, a BMJ publication.
Dr Chancellor is married with three adult children.
Multiple Sclerosis in 2018
Multiple Sclerosis (MS) is a chronic immune mediated disorder of the central nervous system, although the precise antigenic target, activation and regulation of adaptive immune responses are poorly understood. Nevertheless, progress has been made in understanding the etiopathogenetic of MS, a disorder with strong genetic and environmental influences. The stakes for people with MS (pMS), in terms of relapse and disability prevention are very much a focus of attention, with sixteen disease-modifying treatments (DMT) approved worldwide - several of which are available in NZ. This paper will briefly review the concept of ‘the clinically isolated syndrome’; discuss the 2017 modifications to the diagnostic criteria for MS and consider the interface between acute medical services and emerging provisions for pMS in specialist medical, nursing and rehabilitation facilities.